For the carcinogen-induced HCC animal model, increased FGF21 levels were observed in the early and middle stages of tumorigenesis, and also in normal hepatocytes adjacent to the tumor foci, while sharply diminished once cells progressed to malignancy. This evidence concerns the gene FGF21 and neoplasm.